MTCH vs REGN · P/E 13, rev $3.48B vs P/E 14, rev $14.34B
Match Group Inc (MTCH) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Match Group Inc (MTCH) is a internet content & information company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported MTCH revenue for 2024-12-31 was $3.48B. Net income was $551.3M. Revenue was up 3.4% from 2023-12-31 to 2024-12-31. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
MTCH currently screens at market cap $8.24B and trailing P/E 13.5. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the MTCH and REGN stock pages for the full models.
Not investment advice.